Last CNY8.15 CNY
Change Today -0.04 / -0.49%
Volume 26.3M
As of 2:05 AM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

nanjing pharmaceutical co-a (600713) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/16/14 - CNY8.68
52 Week Low
01/13/14 - CNY4.91
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NANJING PHARMACEUTICAL CO-A (600713)

Related News

No related news articles were found.

nanjing pharmaceutical co-a (600713) Related Businessweek News

No Related Businessweek News Found

nanjing pharmaceutical co-a (600713) Details

Nanjing Pharmaceutical Co., Ltd. is primarily engaged in manufacture and distribution of Chinese medicines and western drugs in China. It is involved in the pharmaceutical distribution operations, which include operation of regular chain drug stores, delivery of pharmaceuticals, supply chain management, logistics services, and others; and pharmaceutical production operations providing Chinese patent medicines, tablets, capsules, granules, solvents, bulk drugs, and others. The company is also engaged in the asset management business, which includes credit guarantee and international trading, as well as provides hotel and information services. Nanjing Pharmaceutical Co., Ltd. was founded in 1951 and is based in Nanjing, the People’s Republic of China.

Founded in 1951

nanjing pharmaceutical co-a (600713) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nanjing pharmaceutical co-a (600713) Key Developments

NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months of 2014

NanJing Pharmaceutical Company Limited reported earnings results for the nine months of 2014. For the period, basic earning per share was CNY 0.074. Weighted average return on net assets was 4.982%.

NanJing Pharmaceutical Company Limited, Board Meeting, Oct 29, 2014

NanJing Pharmaceutical Company Limited, Board Meeting, Oct 29, 2014. Agenda: To discuss and approve the issues including third quarter report of 2014 and its abstract; to consider the proposal of changing accounting policy; and to consider the proposal of appointing senior management members.

NanJing Pharmaceutical Company Limited to Report Q3, 2014 Results on Oct 31, 2014

NanJing Pharmaceutical Company Limited announced that they will report Q3, 2014 results on Oct 31, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600713:CH CNY8.15 CNY -0.04

600713 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huadong Medicine Co Ltd CNY52.22 CNY +0.27
Jointown Pharmaceutical Group Co Ltd CNY17.44 CNY +0.60
Shanghai Pharmaceuticals Holding Co Ltd CNY14.91 CNY -0.05
Wanjia Group Holdings Ltd $0.50 HKD -0.02
View Industry Companies

Industry Analysis


Industry Average

Valuation 600713 Industry Range
Price/Earnings 85.7x
Price/Sales 0.3x
Price/Book 5.5x
Price/Cash Flow 86.3x
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NANJING PHARMACEUTICAL CO-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at